ChecklistGuro logo ChecklistGuro Soluciones Industrias Recursos Precios

Pharmaceutical Annual Product Review (APR) Checklist

Ensure regulatory compliance and maintain product quality with our Pharmaceutical Annual Product Review (APR) Checklist. Streamline your APR process, identify trends, and drive continuous improvement - all in one easy-to-use template. Perfect for GxP environments.

Esta plantilla se instaló 5 veces.

Estilo de visualización

Commercial Data Review

1 of 10

Assessment of sales, market trends, and competitive landscape.

Total Sales Revenue (USD)

Units Sold

Market Share (%)

Primary Market Segment

Last Sales Data Update Date

Summary of Market Trends

Quality Performance Evaluation

2 of 10

Review of quality metrics, including deviations, CAPAs, and complaints.

Total Number of Deviations

Number of CAPAs Opened

Number of Customer Complaints Received

Overall Quality System Rating (e.g., Excellent, Good, Needs Improvement)

Last Internal Audit Date

Summary of Significant Quality Trends

Were there any critical deviations? (Yes/No)

Supporting Documentation (e.g., Deviation Reports, Audit Findings)

Stability Data Analysis

3 of 10

Evaluation of ongoing stability data to confirm product expiry dates and storage conditions.

Review Date

Batch Number

Temperature (°C)

Humidity (%)

Stability Protocol Followed

Visual Inspection Results (Scale 1-5, 1=Excellent, 5=Unacceptable)

Detailed Observations & Comments

Attached Stability Data Reports

Manufacturing Process Review

4 of 10

Assessment of manufacturing processes, including efficiency, yield, and quality control.

Overall Yield (%)

Process Efficiency (%)

Description of any Process Deviations

Equipment Performance Rating (Excellent, Good, Fair, Poor)

Date of Last Equipment Maintenance

Attachment: Process Validation Report (if applicable)

Summary of Improvements Implemented This Year

Regulatory Compliance Update

5 of 10

Verification of adherence to current regulatory requirements and identification of potential changes.

Last Regulatory Inspection Date

Applicable Regulatory Frameworks (e.g., cGMP, EU GMP)

Summary of Regulatory Updates (new guidelines, interpretations)

Number of Significant Regulatory Changes Identified

Status of Outstanding Regulatory Actions (if any)

Supporting Documentation (e.g., inspection reports, regulatory correspondence)

Product Labeling and Packaging Review

6 of 10

Assessment of labeling accuracy, compliance, and packaging integrity.

Labeling Revision Status

Primary Label Revision Date

Labeling Change Justification

Current Primary Label Image

Packaging Material Compliance

Tamper-Evident Features Verification (Quantity)

Packaging Defects Observed (if any)

Next Labeling Review Date

Risk Assessment & Mitigation

7 of 10

Identification of potential risks associated with the product and evaluation of existing mitigation strategies.

Identify Potential Risks

Risk Priority Score (1-10)

Risk Category (e.g., Quality, Manufacturing, Regulatory)

Existing Mitigation Strategies

Severity Assessment (Select all that apply)

Proposed Additional Mitigation Actions (if needed)

Implementation Date of New Mitigation Actions

Reviewer Signature

Post-Market Surveillance Data

8 of 10

Review of adverse event reports and other post-market surveillance data.

Number of Adverse Event Reports Received

Summary of Significant Adverse Event Trends

Review of Periodic Safety Update Reports (PSURs)

Supporting Documentation (e.g., Trend Analysis Reports)

Date of Last PSUR Submission

Signal Detection Activities Performed

Lifecycle Management Considerations

9 of 10

Discussion of potential product enhancements, line extensions, or discontinuation plans.

Potential Product Enhancements (Formulation, Dosage Form)

Potential Line Extensions (New Indications, Patient Populations)

Estimated Market Size for Line Extension (Units/Year)

Target Date for Line Extension Launch (if applicable)

Potential Product Discontinuation (if applicable)

Justification for Discontinuation (if applicable)

Impact Assessment (if product discontinued)

Summary and Recommendations

10 of 10

Consolidation of findings and suggestions for future actions.

Overall Summary of APR Findings

Proposed Budget Increase/Decrease (%)

Date of Next Review

Recommended Actions (select all that apply)

Responsible Party for Action Implementation

Reviewer Signature

¿Le resultó útil esta plantilla de lista de verificación?

Demostración de la Solución de Gestión Farmacéutica

¿Está buscando cumplir con regulaciones complejas y garantizar la calidad en la fabricación farmacéutica? La plataforma Work OS de ChecklistGuro optimiza los procesos, desde la investigación y desarrollo hasta la producción, el envasado y la distribución. Mantenga el cumplimiento normativo, mejore la eficiencia y reduzca los riesgos. ¡Descubra cómo ChecklistGuro puede transformar sus operaciones farmacéuticas!

Plantillas de listas de verificación relacionadas

Podemos hacerlo juntos

¿Necesita ayuda con las listas de verificación?

¿Tienes alguna pregunta? Estamos aquí para ayudarte. Envía tu consulta y te responderemos a la brevedad.

Correo electrónico
¿Cómo podemos ayudarte?